Functional Characterization of a High-Throughput in vitro Model to
Predict Faecal Microbiota Transplantation (FMT) Donor Success
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INTRODUCTION
•
•
•

•
•

•

FMT has emerged in recent years as a potential therapy for a variety of
microbiome-associated diseases, such as atherosclerosis.
In vitro models are lacking to study mechanisms of treatment success
and donor-recipient compatibility.
Trimethylamine (TMA) is an atherosclerosis-linked metabolite
generated by the gut microbiota from dietary precursors, which is then
oxidized to trimethylamine N-oxide (TMAO) by the liver.
FMT may alter or restore the gut microbiome of recipients to reduce
plasma TMAO levels.
A 96 well plate-based culturing model (MiPro)¹ was adopted and
modified to identify the response of FMT donor and atherosclerosis
patient microbiomes to TMA metabolites.
The modified model was used to investigate TMA production and its
influence on barrier integrity in a sample population of atherosclerosis
patients with high plasma TMAO (n=2) and donors (n=4).

RESULTS

DISCUSSION
• Significant differences in monolayer barrier integrity measured
by TEER were observed following treatment with filtered donor
MiPro effluent.
• Donor 3 was especially resilient, with increases in cell barrier
integrity observed post-treatment with filtered effluent.
• FMT recipients exhibited decreases in monolayer barrier
integrity measured by TEER following treatment with filtered
effluent.

Fig. 2. Donors demonstrate significant differences in epithelial barrier permeability following
treatment with filtered MiPro effluent. Caco-2:HT29-MTX-E12 cell monolayers were grown to
confluency on a nitrocellulose transmembrane over 14 days. The mean change in
transepithelial electrical resistance (TEER) (Ωcm²) was measured using an epithelial volt/ohm
meter (EVOM) following 24 hours of filtered effluent treatment. Negative values indicate
increased barrier permeability. Significant differences post-treatment (indicated by decreased
opacity) were observed between donors (n=4) using a one-way ANOVA at ****p<0.0001. Error
bars represent standard errors of the mean.

(A)

• Barrier integrity measured by ZO-1 signal was notably
disrupted amongst donors and recipients post-effluent
treatment, with the largest changes observed in Donor 3.
• This study provides proof of concept of a novel highthroughput in vitro model to predict donor microbiota
resilience upon exposure to toxic metabolites such as TMA.
• Future projects correcting for the small sample size of this
study may allow for identification of specific FMT donor
microbiota characteristics implicated in therapeutic success.

(B)

Objective: To characterize the effects of microbiome samples from
individuals with divergent disease phenotypes on intestinal barrier
integrity to identify characteristics implicated in FMT donor success.
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METHODS
Fig. 1. Method of
effluent collection
from the modified
MiPro model
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